The Mesotherapy Market analysis report by Future Market Insights shows that global sales of the mesotherapy market in 2021 were held at US$ 134.2 Million. With a CAGR of 17.5% from 2022 to 2032, the market is projected to reach a valuation of US$ 768 Million by 2032. Mesotherapy Solutions is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 21.5% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Mesotherapy Market (2022) | US$ 154.8 Million |
| Global Mesotherapy Market (2032) | US$ 768 Million |
| Global Mesotherapy Market CAGR (2022 to 2032) | 17.5% |
| US Mesotherapy Market CAGR (2022 to 2032) | 19.7% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Mesotherapy Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Mesotherapy Market increased at around 14.3% CAGR. With an absolute dollar opportunity of US$ 613 Million from 2022 to 2032, the market in the country is expected to reach a valuation of US$ 768 Million by 2032.
The mesotherapy industry is rapidly being affected by Mesotherapy Solutions in an effort to encourage patient participation in their sector to gather data. The market for analytics data concerning patient welfare is slowly being stimulated by the growing demand for consumer analysis.
Some of the factors driving market expansion include the rising popularity of mesotherapy amongst some of the middle-aged population who are self-conscious about their appearance. As a result, the expanding number of aesthetic clinics offering mesotherapy treatments is projected to increase demand for mesotherapy. Furthermore, increased medical tourism for aesthetic operations is adding to the market's expansion.
The therapy is increasingly being employed for skin rejuvenation operations in both developing and developed countries. Consumers have a vast range of mesotherapy products to choose from, including peels, solutions, lotions, masks, and dermal fillers. The advantages of mesotherapy, such as its minimally invasive character, cost-effectiveness, and ease of product availability, are key factors driving the growth of the mesotherapy market.
Being non-invasive and comparatively low cost of treatment are the main reasons for the Mesotherapy market growth. The number of competent and licensed professionals in dermatology clinics around the world has been increasing. The developments in the number of mesotherapy institutes and the efforts of the International Society of Mesotherapy to cultivate acceptable mesotherapy practice have positively impacted the quality of mesotherapy and benefited the market in recent years.
Principal Consultant
The rise in cosmetic treatment adoption, mind fashion sense among the middle-aged population, and an increase in the number of cosmetic centers offering mesotherapy are likely to fuel market expansion. The technique is painless and takes less time, and it is expected to assist replace more difficult skin rejuvenation processes, creating new prospects for the worldwide mesotherapy market. Mesotherapy is regarded as a relatively recent type of skin treatment.
In 2021, North America held the largest share of the global Mesotherapy Market with a CAGR of 14.3%. The market in the region has been impacted owing to the growing middle-aged population who are worried about their looks and a rise in the number of beauty clinics providing mesotherapy solutions.
Due to the growing mesotherapy expenditure of South Korea, Japan, and China and factors such as the growing geriatric population, Asia Pacific is projected to grow at the fastest rate throughout the projection period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
US Mesotherapy Market Analysis
The United States is expected to account for the largest market of US$ 168.2 million by the end of 2032. Rising consumer disposable incomes, as well as increased care about aesthetic appearance, have been leading to market growth. Furthermore, increased age concerns, changing climatic circumstances, changes in lifestyle, and stress are all contributing to an increase in demand for mesotherapy. Furthermore, the manufacturing businesses' extensive distribution network has enabled mesotherapy products’ availability throughout the globe. Besides, rising media and internet saturation have raised product awareness, expertise, and ease of access.
U.K. Mesotherapy Market Analysis
The market for mesotherapy is expected to reach a valuation of US$ 53.7 Million by 2032. Growing at a CAGR of 18.9% from 2022 to 2032, the market in the country is projected to gross an absolute dollar opportunity of US$ 44.2 Million.
China Mesotherapy Market Analysis
The market in China is expected to register US$ 77 Mn by 2032 at a CAGR of 15.7% from 2022 to 2032. During the forecast period, the market in the country is expected to gross an absolute dollar opportunity of US$ 59 Million.
Japan Mesotherapy Market Analysis
In Japan, the market is expected to garner a market of US$ 30.3 Million by 2032. With a projected CAGR of 17%, the market in the country is expected to gross an absolute dollar opportunity of US$ 24 Million during the forecast period.
South Korea Mesotherapy Market Analysis
The market in South Korea is projected to garner an absolute dollar opportunity of US$ 13.3 Million from 2022 to 2032. With a CAGR of 16.2% from 2022 to 2032, the market in the country is projected to garner an absolute dollar opportunity of US$ 13.3 Million.
The market for Mesotherapy Solutions is forecasted to grow at a CAGR of over 21.5% from 2022 to 2032. This growth is due to the escalating demand for enhanced analyses based on historical patterns and datasets to generate data-enriched insight that will help organizations better understand the current situation.
The anti-aging segment is forecasted to grow at the highest CAGR of over 19% from 2022 to 2032. Because of the growing middle-aged population, increased disposable income, and low-cost procedures, the anti-aging category accounted for the fastest growth in this segment.
Mesotherapy Solutions commanded the largest revenue and is expected to grow at a CAGR of over 21%, during the forecast period. Mesotherapy solutions are customized for each patient and may include phosphatidylcholine and deoxycholate as well as hyaluronic acid, vitamins, nonsteroidal anti-inflammatories, proteins, minerals, antibiotics, and hormones. It is generally used for fat removal and contouring, but it may also be used as a painkiller, cellulite reduction, and hair loss.
Some of the key companies operating in the mesotherapy market include Koru Pharmaceuticals Co. Ltd., AbbVie Inc., Galderma Laboratories, L.P., Mesoskinline, Institute BCN, Fusion Meso, and Mesoestetic.
Some of the recent developments of key mesotherapy providers are as follows:
Similarly, recent developments related to companies in the Mesotherapy Services have been tracked by the team at Future Market Insights, which are available in the full report.
At present, the mesotherapy market is valued at US$ 134.2 million.
The value of the Mesotherapy Market is projected to increase at a CAGR of around 17.5% from 2022 to 2032.
The value of the Mesotherapy Market increased at a CAGR of around 14.3% from 2017 to 2021.
The market for Mesotherapy in China is projected to expand at a CAGR of around 15.7% from 2022 to 2032.
While the market in South Korea is expected to grow at nearly 16.2%, the market in Japan is projected to register a CAGR of 17% from 2022 to 2032.
1. Executive Summary | Mesotherapy Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Investment Feasibility Matrix
3.4. Regulatory Landscape
3.4.1. By Key Regions
3.4.2. By Key Countries
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2022 to 2032
5.3.1. Solutions
5.3.2. Masks
5.3.3. Creams
5.3.4. Devices
5.3.5. Other Types
5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032
6.3.1. Anti-aging
6.3.2. Facial Rejuvenation
6.3.3. Stretch Marks
6.3.4. Acne & Scar Treatment
6.3.5. Fat Loss
6.3.6. Hair Loss
6.3.7. Other Applications
6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2017 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2022 to 2032
7.3.1. Hospitals
7.3.2. Dermatology & Cosmetic Clinics
7.3.3. Other End-uses
7.4. Y-o-Y Growth Trend Analysis By End-use, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By End-use, 2022 to 2032
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. Middle East & Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. The US
9.2.1.2. Canada
9.2.2. By Type
9.2.3. By Application
9.2.4. By End-use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Application
9.3.4. By End-use
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Rest of Latin America
10.2.2. By Type
10.2.3. By Application
10.2.4. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Application
10.3.4. By End-use
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. The UK
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Type
11.2.3. By Application
11.2.4. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Application
11.3.4. By End-use
11.4. Key Takeaways
12. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Type
12.2.3. By Application
12.2.4. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Application
12.3.4. By End-use
12.4. Key Takeaways
13. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Type
13.2.3. By Application
13.2.4. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Application
13.3.4. By End-use
13.4. Key Takeaways
14. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Type
14.2.3. By Application
14.2.4. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Application
14.3.4. By End-use
14.4. Key Takeaways
15. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
15.2.1. By Country
15.2.1.1. GCC
15.2.1.2. Rest of MEA
15.2.2. By Type
15.2.3. By Application
15.2.4. By End-use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type
15.3.3. By Application
15.3.4. By End-use
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. The US
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Type
16.1.2.2. By Application
16.1.2.3. By End-use
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Type
16.2.2.2. By Application
16.2.2.3. By End-use
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Type
16.3.2.2. By Application
16.3.2.3. By End-use
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Type
16.4.2.2. By Application
16.4.2.3. By End-use
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Type
16.5.2.2. By Application
16.5.2.3. By End-use
16.6. Germany
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2021
16.6.2.1. By Type
16.6.2.2. By Application
16.6.2.3. By End-use
16.7. Italy
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2021
16.7.2.1. By Type
16.7.2.2. By Application
16.7.2.3. By End-use
16.8. France
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2021
16.8.2.1. By Type
16.8.2.2. By Application
16.8.2.3. By End-use
16.9. The UK
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2021
16.9.2.1. By Type
16.9.2.2. By Application
16.9.2.3. By End-use
16.10. Spain
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2021
16.10.2.1. By Type
16.10.2.2. By Application
16.10.2.3. By End-use
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2021
16.11.2.1. By Type
16.11.2.2. By Application
16.11.2.3. By End-use
16.12. BENELUX
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2021
16.12.2.1. By Type
16.12.2.2. By Application
16.12.2.3. By End-use
16.13. China
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2021
16.13.2.1. By Type
16.13.2.2. By Application
16.13.2.3. By End-use
16.14. Japan
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2021
16.14.2.1. By Type
16.14.2.2. By Application
16.14.2.3. By End-use
16.15. South Korea
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2021
16.15.2.1. By Type
16.15.2.2. By Application
16.15.2.3. By End-use
16.16. India
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2021
16.16.2.1. By Type
16.16.2.2. By Application
16.16.2.3. By End-use
16.17. Thailand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2021
16.17.2.1. By Type
16.17.2.2. By Application
16.17.2.3. By End-use
16.18. Malaysia
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2021
16.18.2.1. By Type
16.18.2.2. By Application
16.18.2.3. By End-use
16.19. Indonesia
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2021
16.19.2.1. By Type
16.19.2.2. By Application
16.19.2.3. By End-use
16.20. Australia
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2021
16.20.2.1. By Type
16.20.2.2. By Application
16.20.2.3. By End-use
16.21. New Zealand
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2021
16.21.2.1. By Type
16.21.2.2. By Application
16.21.2.3. By End-use
16.22. GCC Countries
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2021
16.22.2.1. By Type
16.22.2.2. By Application
16.22.2.3. By End-use
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Type
17.3.3. By Application
17.3.4. By End-use
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Koru Pharmaceuticals Co. Ltd.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. AbbVie Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Galderma Laboratories, L.P.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Mesoskinline
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Institute BCN
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Fusion Meso
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Mesoestetic
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Mesotherapy Market
